MA51576A - POLYTHERAPY - Google Patents

POLYTHERAPY

Info

Publication number
MA51576A
MA51576A MA051576A MA51576A MA51576A MA 51576 A MA51576 A MA 51576A MA 051576 A MA051576 A MA 051576A MA 51576 A MA51576 A MA 51576A MA 51576 A MA51576 A MA 51576A
Authority
MA
Morocco
Prior art keywords
polytherapy
Prior art date
Application number
MA051576A
Other languages
French (fr)
Inventor
Hugh Griffith
Original Assignee
NuCana plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2015/054158 external-priority patent/WO2017109444A1/en
Priority claimed from GBGB1609770.1A external-priority patent/GB201609770D0/en
Application filed by NuCana plc filed Critical NuCana plc
Publication of MA51576A publication Critical patent/MA51576A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA051576A 2015-12-23 2016-12-21 POLYTHERAPY MA51576A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/GB2015/054158 WO2017109444A1 (en) 2015-12-23 2015-12-23 Combination therapy
GBGB1609770.1A GB201609770D0 (en) 2016-06-03 2016-06-03 Combination therapy

Publications (1)

Publication Number Publication Date
MA51576A true MA51576A (en) 2020-11-18

Family

ID=57681677

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051576A MA51576A (en) 2015-12-23 2016-12-21 POLYTHERAPY

Country Status (29)

Country Link
US (2) US20190022117A1 (en)
EP (2) EP3738595A1 (en)
JP (1) JP6898329B2 (en)
KR (1) KR20180096698A (en)
CN (1) CN108697725A (en)
AU (1) AU2016375861B2 (en)
CA (1) CA3008749C (en)
CY (1) CY1122835T1 (en)
DK (1) DK3393478T3 (en)
EA (1) EA037459B1 (en)
ES (1) ES2778933T3 (en)
HR (1) HRP20200423T1 (en)
HU (1) HUE050290T2 (en)
IL (1) IL260076A (en)
LT (1) LT3393478T (en)
MA (1) MA51576A (en)
MD (1) MD3393478T2 (en)
ME (1) ME03677B (en)
MX (1) MX383988B (en)
MY (1) MY194629A (en)
PH (1) PH12018501339A1 (en)
PL (1) PL3393478T3 (en)
PT (1) PT3393478T (en)
RS (1) RS60211B1 (en)
SG (1) SG11201805184TA (en)
SI (1) SI3393478T1 (en)
SM (1) SMT202000154T1 (en)
WO (1) WO2017109486A1 (en)
ZA (1) ZA201804155B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013346515B2 (en) 2012-11-16 2017-05-25 NuCana plc Process for preparing nucleoside prodrugs
EA033046B1 (en) 2014-06-25 2019-08-30 НУКАНА ПиЭлСи Formulation comprising a gemcitabine-prodrug
RS60968B1 (en) 2014-06-25 2020-11-30 NuCana plc Gemcitabine prodrugs
GB201417644D0 (en) 2014-10-06 2014-11-19 Nucana Biomed Ltd Method of separating phosphate diastereoisomers
PH12018500691B1 (en) 2015-10-05 2022-08-10 NuCana plc Combination therapy
CA3007347C (en) 2015-12-11 2020-08-04 NuCana plc Diastereoselective synthesis of phosphate derivatives and of the gemcitabine prodrug nuc-1031
GB201522771D0 (en) 2015-12-23 2016-02-03 Nucana Biomed Ltd Crystalline form of a phosphate derivative
GB201709471D0 (en) 2017-06-14 2017-07-26 Nucana Biomed Ltd Diastereoselective synthesis of hosphate derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0317009D0 (en) * 2003-07-21 2003-08-27 Univ Cardiff Chemical compounds
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
EA201491629A1 (en) * 2012-08-13 2015-08-31 Регулон, Инк. METHODS OF TREATMENT CANCER USING LIPOPLATIN
JP6420247B2 (en) * 2012-11-13 2018-11-07 ボーイエン セラピューティクス,インコーポレイティド Gemcitabine prodrug and use thereof
CN107835687A (en) * 2015-05-14 2018-03-23 努卡那有限公司 cancer treatment
PH12018500691B1 (en) * 2015-10-05 2022-08-10 NuCana plc Combination therapy

Also Published As

Publication number Publication date
US20190022117A1 (en) 2019-01-24
JP2019509253A (en) 2019-04-04
MX2018007772A (en) 2019-07-04
WO2017109486A1 (en) 2017-06-29
SMT202000154T1 (en) 2020-05-08
HK1255110A1 (en) 2019-08-02
US20230149436A1 (en) 2023-05-18
ME03677B (en) 2020-10-20
KR20180096698A (en) 2018-08-29
EA201891473A1 (en) 2019-01-31
PH12018501339A1 (en) 2019-02-18
ZA201804155B (en) 2021-06-30
LT3393478T (en) 2020-04-10
DK3393478T3 (en) 2020-03-23
MY194629A (en) 2022-12-07
EP3738595A1 (en) 2020-11-18
CY1122835T1 (en) 2021-05-05
AU2016375861B2 (en) 2021-12-23
MX383988B (en) 2025-03-14
CA3008749C (en) 2024-01-02
MD3393478T2 (en) 2020-04-30
PL3393478T3 (en) 2020-07-13
BR112018012956A2 (en) 2019-01-08
PT3393478T (en) 2020-03-24
JP6898329B2 (en) 2021-07-07
CN108697725A (en) 2018-10-23
CA3008749A1 (en) 2017-06-29
SG11201805184TA (en) 2018-07-30
RS60211B1 (en) 2020-06-30
HRP20200423T1 (en) 2020-09-04
SI3393478T1 (en) 2020-07-31
HUE050290T2 (en) 2020-11-30
IL260076A (en) 2018-07-31
EP3393478A1 (en) 2018-10-31
ES2778933T3 (en) 2020-08-12
EA037459B1 (en) 2021-03-30
EP3393478B1 (en) 2020-03-04
AU2016375861A1 (en) 2018-07-05

Similar Documents

Publication Publication Date Title
NL301219I2 (en) teclistamab
DK3283625T3 (en) NUCLEASE-MEDIED GENOMEDITING
EP3286361A4 (en) KREBSNEOEPITOPE
DK3331869T3 (en) MUSCARINAGONISTS
DK3331528T3 (en) MUSCARINAGONISTS
DK3277719T3 (en) POLYPEPTIDER
EP3316375A4 (en) REDOXDURCHFLUSSZELLE
DK3360890T3 (en) GENTERAPHY
DK3305788T3 (en) JANUS-KINASE-HIMMER
DK3331529T3 (en) MUSCARINAGONISTS
EP3290364A4 (en) FÖRDERBANDVERSCHLEISSÜBERWACHUNGSSYSTEM
DK3310450T3 (en) OIL-WATER-SEPARATOR
MA47676A (en) POLYTHERAPY
MA46285A (en) POLYTHERAPY
DK3394281T3 (en) GÆRCELLLE
EP3297518B1 (en) VIDEOLARYNGOSKOP
DK3270930T3 (en) PRE-CLAMPSY
EP3381654A4 (en) FLÜSSIGBLASFORMVERFAHREN
ME03677B (en) POLYTHERAPY
EP3363322A4 (en) HAARVERLÄNGERER
EP3668507A4 (en) POLYTHERAPY
DK3292136T3 (en) PENICILLIN-G-ACYLASER
DK3274482T3 (en) STENBORSKNOP
DE112015006486A5 (en) Inkubationsrinne
EP3377179A4 (en) EPI-743 DEUTTERATED